Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
Should we care about sativex-induced neurobehavioral effects? A 6-month follow-up study.
Rasch analysis of SF-Qualiveen in multiple sclerosis.
Latent profile analysis of regression-based norms demonstrates relationship of compounding MS symptom burden and negative work events.
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Optical Coherence Tomography for the Neurologist.
Characterizing absolute lymphocyte count profiles in dimethyl fumarate-treated patients with MS: Patient management considerations.
Patient wins right to care at home.
A multiple sclerosis-like disorder in patients with OPA1 mutations.
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.
Cerebral vasomotor reactivity in neurodegenerative diseases.
Administrative databases for observational studies in multiple sclerosis: power or peril?
The epidemiology of multiple sclerosis: insights to a causal cascade.
Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
Enabling specialist nurses to prove their value.
Placental Stromal Cell Therapy for Experimental Autoimmune Encephalomyelitis: The Role of Route of Cell Delivery.
Implementation of a Coherent Anti-Stokes Raman Scattering (CARS) System on a Ti:Sapphire and OPO Laser Based Standard Laser Scanning Microscope.
Oligodendroglial deletion of ESCRT-I component TSG101 causes spongiform encephalopathy.
Engineering tolerance using biomaterials to target and control antigen presenting cells.
Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage.
TLR Tolerance as a Treatment for Central Nervous System Autoimmunity.
PREVAIL: Predicting Recovery through Estimation and Visualization of Active and Incident Lesions.
Using Bayesian hierarchical models to better understand nitrate sources and sinks in agricultural watersheds.
Pages
« first
‹ previous
…
722
723
724
725
726
727
728
729
730
…
next ›
last »